Schedule 13G ownership disclosure

BeiGene, Ltd.

Security class unavailable · CUSIP: G1146Y101

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
110,215,170
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562230-23-000016
Form type
SC 13G/A
Filer
BeOne Medicines Ltd.
CIK
CIK 1651308
Filed
Feb 13, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub